Is PCP Fat-Soluble?
Yes, phencyclidine (PCP) is highly fat-soluble (lipophilic), which allows it to accumulate extensively in adipose tissue and cross biological membranes readily, including the blood-brain barrier.
Pharmacokinetic Properties
PCP demonstrates significant lipophilicity, which fundamentally shapes its distribution and clinical effects:
Large volume of distribution: PCP has a volume of distribution averaging 6.2 ± 0.3 L/kg 1, indicating extensive tissue distribution far beyond plasma volume. This large volume reflects its lipophilic nature and ability to partition into fatty tissues.
Tissue accumulation: Research demonstrates that PCP concentrates substantially in fat tissue, with studies showing significant drug levels in adipose tissue following administration 2. The lipophilic structure enables PCP to dissolve in and accumulate within fat stores throughout the body.
Brain penetration: The fat-soluble nature of PCP allows rapid and extensive brain penetration. Studies show substantial brain concentrations, with anti-PCP antibody therapy reducing brain area under the curve to only 23% of controls—demonstrating how readily PCP normally enters and remains in brain tissue 2.
Chemical Structure and Lipophilicity
PCP's arylcyclohexylamine structure confers high lipid solubility 3. The molecule contains:
- A cyclohexane ring system
- An aromatic phenyl group
- A piperidine moiety
This combination creates a predominantly non-polar, lipophilic compound that readily crosses lipid membranes.
Clinical Implications
The fat solubility of PCP has important clinical consequences:
Prolonged elimination: The terminal half-life averages 21 ± 3 hours (harmonic mean 17 hours, range 7-46 hours) 1, partly due to redistribution from fat stores back into circulation.
Extensive tissue distribution: PCP distributes widely to brain, fat, heart, kidney, liver, lung, muscle, and testis 2. Fat tissue serves as a reservoir, slowly releasing drug over time.
High plasma protein binding: Approximately 65% of PCP binds to plasma proteins 1, consistent with its lipophilic character.
Metabolism-dependent clearance: Only 9% of total clearance occurs via renal excretion; the remaining 91% requires hepatic metabolism 1, as the lipophilic molecule cannot be efficiently excreted unchanged in urine.